CITADEL ADVISORS LLC - 14 Nov 2025 SCHEDULE 13G Report for Acrivon Therapeutics, Inc. Common Stock, par value $0.001 per share (the "Shares") (ACRV)

Filing Manager
CITADEL ADVISORS LLC
Reporting Manager
Kenneth Griffin
Security
Acrivon Therapeutics, Inc. Common Stock, par value $0.001 per share (the "Shares")
Symbol
ACRV
Shares outstanding
31,306,673 shares
Disclosed Ownership
1,721,867 shares
Ownership
5.5%
Form type
SCHEDULE 13G
Filing time
21 Nov 2025, 17:36:58 UTC
Date of event
14 Nov 2025
Previous filing
14 Nov 2025
SEC
View on sec.gov

Reporting Managers (7)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Citadel Advisors LLC 4.9% 1,541,326 0 1,541,326 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Advisors Holdings LP 4.9% 1,541,326 0 1,541,326 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel GP LLC 4.9% 1,541,326 0 1,541,326 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Securities LLC 0.6% 180,541 0 180,541 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Securities Group LP 0.6% 180,541 0 180,541 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Securities GP LLC 0.6% 180,541 0 180,541 /s/ Seth Levy Seth Levy, Authorized Signatory
Kenneth Griffin 5.5% 1,721,867 0 1,721,867 /s/ Seth Levy Seth Levy, attorney-in-fact*